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Elongating Escherichia coli RNAP is modulated by
NusA protein. The C-terminal domain (CTD) of the
RNAP a subunit (aCTD) interacts with the acidic
CTD 2 (AR2) of NusA, releasing the autoinhibitory
blockade of the NusA S1-KH1-KH2 motif and allow-
ing NusA to bind nascent nut spacer RNA. We deter-
mined the solution conformation of the AR2:aCTD
complex. The aCTD residues that interface with
AR2 are identical to those that recognize UP pro-
moter elements A nusA-DAR2 mutation does not
affect UP-dependent rrnH transcription initiation
in vivo. Instead, themutation inhibits Rho-dependent
transcription termination at phage l tR1, which lies
adjacent to the l nutR sequence. The Rho-depen-
dent l timm terminator, which is not preceded by a
l nut sequence, is fully functional. We propose that
constitutive binding of NusA-DAR2 to l nutR
occludes Rho. In addition, the mutation confers a
dominant defect in exiting stationary phase.
INTRODUCTION
The three distinct steps of transcription, that is, initiation, elonga-
tion, and termination, are highly regulated by transcription
factors and genetic signals encoded in DNA or RNA (Severinov,
2000). In E. coli, transcription initiation is mediated by the six
subunit (sa2bb’u) RNA polymerase holoenzyme (RNAP)
(Mooney et al., 2005). The N-terminal domains (NTD) of the two
a subunits are part of the structurally well-defined RNAP
nucleus, whereas transcription initiation is controlled, in part,
by the a subunit C-terminal domain (aCTD). Regulatory factors
such as catabolite activator protein (CAP), MarA, or SoxR bind
to aCTD and increase initiation rates at specific promoters (Ben-
off et al., 2002; Shah andWolf, 2004; Zou et al., 1992). The aCTDStructure 19,also interacts with cis-acting DNA sequences upstream of rrn
promoters (UP elements), thereby increasing the basal transcrip-
tion level by about two orders of magnitude (Ross et al., 1993).
Structurally, a key motif of the aCTD is a compact globular
domain of two helix-hairpin-helix motifs linked via a connecting
helix, the (Helix-hairpin-Helix)2, or (HhH)2, fold (Jeon et al.,
1995). This fold was originally identified as a nucleic acid binding
motif, but it is also known as a module for protein-protein inter-
action (Shao and Grishin, 2000).
The highly conserved 55 kDa monomeric NusA protein
attaches to RNAP shortly after transcription initiation (Mooney
et al., 2009). NusA slows the rate of transcription elongation
and stimulates intrinsic and, possibly, Rho-dependent transcrip-
tion termination(Cardinale et al., 2008). It is essential for viability
in wild-type E. coli (Cardinale et al., 2008; Schmidt and Cham-
berlin, 1984). Efficient termination is required to silence cryptic
prophage; thus, a nusA mutation carrying a Cam insertion at
amino acid 127 (referred to below as DnusA) can be introduced
into strain MDS42, which is deleted for these elements (Cardi-
nale et al., 2008). NusA also plays a central role in the architec-
ture of the phage l N processive antitermination complex (Mah
et al., 1999). NusA is composed of an NTD, three RNA-binding
motifs S1, KH1, KH2, and two C-terminal acidic repeats (AR1,
AR2) (Liu et al., 1996; Nudler and Gottesman, 2002) that, like
aCTD, form an (HhH)2 fold (Eisenmann et al., 2005). The NTD
interacts with RNAP, and two different binding sites in RNAP
have been proposed. Whereas structural similarity and compet-
itive binding with s70 suggest that the NTD interacts directly with
the RNAP b’ clamp helices (Borukhov et al., 2005), single particle
electron microscopy and protein-RNA crosslinking suggest
a binding site for NusA NTD close to the RNAP RNA exit channel,
possibly by direct interaction with the flap-tip helix (Ha et al.,
2010; Vassylyev, 2009; Yang et al., 2009). As part of the antiter-
mination complex, NusA binds to the spacer region of the l nut
RNA sequence (Prasch et al., 2009). In contrast, isolated full-
length NusA does not bind RNA, but a deletion mutant lacking
AR2 does bind, indicating an autoinhibitory function of AR2.
NusA association with aCTD also permits RNA binding, suggest-
ing that the interaction between aCTD and AR2 relieves NusA945–954, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 945
Figure 1. Affinity of AR2:aCTD
(A) Chemical shift changes in an expanded region
of the 1H,15N HSQC of 15N-labeled AR2 upon
addition of unlabeled aCTD. The arrows mark the
direction of signal shifts during the titration series.
(B) Titration curves for selected residues. Data
fitting using a bimolecular two-state bindingmodel
results in a KD in a range of 1–5 mM (Leu434:
2.8 mM; Ala468: 3.4 mM; Ala480: 1.2 mM). Due to
the high concentration required for the NMR
experiments these results represent an estimate of
the upper limit of the binding affinity.
Table 1. Structural Statistics for AR2:aCTD Complex
Total NOE Distance Restraints 2470
Intermolecular (AR2 – aCTD) 33
Intramolecular (AR2) 1241
Intraresidual 366
Interresidual 323, 330, 222
Sequential, medium, long
Hydrogen Bond Restraints 22
Dihedral Angle Restraints 7
Intramolecular (aCTD) 1196
Intraresidual 470
Interresidual 281, 244, 201
Sequential, medium, long
Hydrogen Bond Restraints 16
Dihedral Angle Restraints 33
<Rmsd> from mean structure
Backbone/heavy atom for
AR2::aCTD (A˚)
0.89
Backbone/heavy atom for AR2 (A˚) 0.36
Backbone/heavy atom for aCTD (A˚) 0.61
Ramachandran statistics (%
residues)
Most Favorable Region 89.3
Additionally Allowed Region 8.5
Generously Allowed Region 2.0
Disallowed Region 0.3
Structure
NusA:RNAP aCTD Complexautoinhibition (Mah et al., 2000). Although their global structures
are nearly identical (Eisenmann et al., 2005), AR1 and AR2 exhibit
entirely different protein binding specificities. AR1 binds lN
(Bonin et al., 2004; Eisenmann et al., 2005; Mah et al., 1999),
whereas no interaction of AR1 with aCTD or of AR2 with lN
has been reported.
Here, we describe the solution structure of the complex
between AR2 and the aCTD of RNAP as well as the inhibitory
interaction between AR2 and the NusA RNA-binding motifs
that is released as a consequence of AR2:aCTD complex
formation.
RESULTS
Structure Determination
Initial solution nuclear magnetic resonance (NMR)-based inter-
action studies using a construct containing 15N-enriched NusA
AR1 and AR2 (Eisenmann et al., 2005) resulted in complete
disappearance of AR2 resonances in the 15N, 1H heteronuclear
single quantum coherence (HSQC) spectra upon addition of
RNAP aCTD(249-329), demonstrating the binding of aCTD to
AR2 but at the same time rendering a determination of the
conformation of the AR2: aCTD complex with this complete
AR1-AR2 construct by solution NMR impossible. Using a con-
struct containing only AR2 greatly improves the quality of the
spectra, and complete resonance assignment of AR2 and
aCTD was possible by application of heteronuclear double-
and triple-resonance NMR experiments. NMR titration experi-
ments using 15N-enriched aCTD allow an upper limit estimate
of the apparent dissociation constant KD in the range of
1–10 mM (Figure 1), consistent with earlier results determined
by gel shift assays (Mah et al., 2000). Experimentally derived
structural restraints (Table 1) allowed the calculation of an
ensemble of structures with reasonable local geometry without
restraint violation. The backbone (N, Ca, C’) coordinates super-
impose with a root mean square deviation (rmsd) of 0.89 A˚ for
the overall complex (0.36 A˚ within AR2, residues 430–491, and
0.61 A˚ within aCTD, residues 249–321).
Structure of the AR2:aCTD Complex
We determined the solution structure of the 19 kDa complex
between AR2(426-495) and aCTD(249-329) by heteronuclear946 Structure 19, 945–954, July 13, 2011 ª2011 Elsevier Ltd All rights reserveddouble- and triple-resonance NMR spec-
troscopy (Figures 2A and 2B). The struc-
tures of AR2 and aCTD in the complexsuperimpose well with their structures in the unbound state
(AR2, pdb entry 1WCN: rmsd 0.94 A˚ for residues 429–491;
aCTD pdb entry 1COO: rmsd 1.9 A˚ for residues 256–310).
Thus, complex formation does not induce significant rearrange-
ment within the domains and can be described as rigid body
interaction. The recognition surface of AR2:aCTD is composed
of a hydrophobic groove at AR2 which contains residues
Ile464 of helix 4 and Ile482, Met483 of helix 5. The aCTD coun-
terpart consists of a hairpin, Lys291-Gly294, between helix 3
and helix 4 (Figure 3A), with Pro293 forming a tip that is deeply
buried in the AR2 pocket.
Figure 2. Solution Structure of the AR2:aCTD Complex
(A) Superposition of the structural ensemble of the AR2 (green):aCTD (red)
complex.
(B) Ribbon representation of the lowest energy structure. Helices are labeled
h1 through h4 for aCTD and h10 through h50 for NusA-AR2, colors as in (A).
Figure 3. Binding Interface of the aCTD:AR2 Complex
(A) The hairpin of aCTD, red, interacts with h4 and h5 of AR2, green. Pro293
and Lys291 of aCTD, red, interact mainly with Met483 and Ile464 of AR2,
green.
(B) The differences between the highly homologous domains NusA AR1
(surface representation: left) and AR2 are evident. Residues 356–414 of NusA-
AR1 have been fitted onto residues 431–490 of AR2 in complex with aCTD
(right; negatively charged residues, red; positively charged residues, blue;
hydrophobic residues, green).
(C) aCTD, gray, in complex with AR2, green. The 261 determinant, yellow,
interacts mainly with the s70 factor, the 265 determinant, red, interacts mainly
with UP elements, and the 287 determinant, blue, interacts with regulatory
proteins such as CAP (Benoff et al., 2002). In the aCTD:AR2 complex, the 265
determinant is blocked by AR2, green, whereas the 287 and 261 determinants
are accessible.
Structure
NusA:RNAP aCTD ComplexThe small AR2:aCTD interaction interface of 694 A˚2 supports
our finding that no large rearrangement takes place upon
complex formation (Lo Conte et al., 1999). The structure of the
AR2:aCTD is the second example of a protein-protein complex
involving two domains with the (HhH)2 fold, in addition to the
ERCC1:XPF complex (Tripsianes et al., 2005; Tsodikov et al.,
2005). In the AR2:aCTD complex only the loop of the second
HhH motif of aCTD interacts with both helices of the second
HhH motif of AR2, whereas in ERCC1:XPF (Tripsianes et al.,
2005; Tsodikov et al., 2005) the (HhH)2 domains are arranged
as an intermolecular four helix bundle with a pseudo-2-fold
symmetry axis and a comparatively large interaction surface.
These different architectures of complexes made up of two
identical interaction motifs seem, however, optimized for their
respective physiological functions: ERCC1:XPF forms a stable
heterodimeric complex that is required for a functional endonu-
clease (Tripsianes et al., 2005; Tsodikov et al., 2005), whereas
NusA and RNAP form a weak and transient complex appropriate
for a regulatory function.
Binding Specificity of NusA Acidic Repeats
Although AR1 andAR2 share high sequence homology and virtu-
ally identical three-dimensional structures, aCTD recognizes
AR2 with high specificity. Interaction of aCTD with AR1 has not
been observed. The role of AR1 is not entirely clear; it binds lNStructure 19,but is not required for N activity in vitro (Bonin et al., 2004; Eisen-
mann et al., 2005; Mah et al., 1999).
The differences in target recognition by AR1 and AR2 become
explicable by closer scrutiny of their respective interaction
surfaces: In the AR1:lN recognition peptide complex, the crucial
feature of AR1 is a hydrophobic patch involving Phe369, Val372,
and Leu398 (Bonin et al., 2004) that forms essential contacts to
Leu40 from lN. An analogous hydrophobic patch on AR2 would945–954, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 947
Figure 4. NusA AR2 Displaces aCTD from the UP Element
(A) Gel retardation experiments detecting displacement of aCTD from an UP
element by purified AR2 domain. All reactions contain 25 mM 32P-labeled wild-
type UP element DNA and an increasing amount of aCTD (up to 100 mM) and
AR2 (up to 250 mM).
(B) Gel retardation experiments detecting displacement of aCTD from an UP
element by full-length NusA and control with NusA AR1. All reactions contain
25 mM 32P-labeled wild-type UP element DNA, increasing amount of aCTD
(up to 100 mM), NusA AR1 (up to 250 mM), and NusA wt (up to 200 mM).
Structure
NusA:RNAP aCTD Complexbe interrupted by Lys447. Similarly, the crucial feature allowing
AR2:aCTD complex formation is a hydrophobic interaction
surface formed by AR2 Ile464, Ile482, and Met483 (Figure 3B),
roughly opposite the AR1:lN recognition site. In AR1, Glu408
and Arg407 replace Met483 and Ile482 in AR2 (Figure 3B), again
abrogating formation of a hydrophobic patch.
The two acidic repeats of NusA and RNAP aCTD share the
(HhH)2 fold. Their interactions with other proteins demonstrate
that despite similar folds, different regions of the proteins are
used for target protein recognition, although in all three cases
the interaction site is represented by small convex or concave
hydrophobic regions. These differences suggest a versatile
role of the (HhH)2 fold as a general protein recognition motif,
but will make prediction of these binding sites challenging.
Transcription Regulation at aCTD
The aCTD contains three discrete sites that bind elements which
regulate RNAP transcriptional activities (Ebright and Busby,
1995; Gaal et al., 1996; Ishihama, 1993; Jeon et al., 1995; Mura-
kami et al., 1996, 1997). The 287 determinant is important for
interaction with activator proteins such as CAP, the 261 determi-
nant interacts with s70-factor, and the 265 determinant recog-
nizes UP elements and the activator proteins MarA and SoxS
(Dangi et al., 2004; Gaal et al., 1996; Shah and Wolf, 2004).
SoxS binding reduces aCTD attachment to UP elements, divert-
ing RNAP to specific SoxS promoter sequences (Shah andWolf,
2004). In obvious analogy, the AR2 interaction site is also located
close to the 265 determinant and occludes the DNA binding site
of aCTD, rendering binding of aCTD to AR2 and binding of aCTD
to UP elements mutually exclusive (Figure 3C).
Preventing or reversing aCTD binding to UP elements would
be expected to affect transcription of rrn operons. By inhibiting
binding, NusA might direct transcription away from rrn toward
other promoters, as is suggested for SoxS (Shah and Wolf
2004). Conversely, reversing aCTD binding might stimulate
escape from rrn promoters. Gel shift experiments demonstrate
that stepwise addition of AR2 released aCTD from a complex
with DNA carrying an UP element, as did full-length NusA. In
contrast, AR1 alone did not release aCTD (Figure 4). This is
consistent with the higher affinity of aCTD for AR2 (KD <10 mM)
compared with the affinity of aCTD to a typical UP element
such as rrnB P1 (KD = 120 mM) (Yasuno et al., 2001). But it should
be noted that this in vitro experiment uses isolated protein
domains and DNA. This may not reflect the real situation, where
the components are tethered together through the RNA
polymerase.
We tested AR2 interaction with UP elements in vivo, using
an rrnH – 16S - luc fusion that carries the rrnH UP element. A
nusA-DAR2 mutant was constructed by recombineering in the
MDS42 background (Sharan et al., 2009). The mutant grows
almost as well as wild-type MDS42, and better than a DnusA
strain. MDS42 wild-type, DnusA, and nusA-DAR2 were assayed
for luciferase in log-phase or after overnight growth. No differ-
ence in luciferase activity was observed among the three strains,
indicating that NusA does not affect UP element activity in vivo
(Table 2). This implies that NusA does not interact with aCTD
until the rrn promoter has been cleared, and is consistent with
the report that NusA competes with s for RNAP core binding
(Greenblatt and Li, 1981).948 Structure 19, 945–954, July 13, 2011 ª2011 Elsevier Ltd All rightAlthough NusA deletions do not affect UP element activity,
they dramatically slow the rate of exit from stationary phase
(Figure 5). MDS42 wild-type, DnusA, and nusA-DAR2 overnight
cultures were diluted into fresh medium and their growth fol-
lowed optically. Both DnusA and nusA-DAR2 strains entered
log phase only after a prolonged lag. In the case of the DnusA
strain, expression of NusA from a plasmid suppressed the out-
growth phenotype. In contrast, the defect of the nusA-DAR2
mutation was dominant. The dominance of the AR2 deletions reserved
Table 2. NusA Does Not Control rrnH Transcription
Strain nus Stationary Log
10916 + 1.2 30.5
10918 nusA-DAR2 1.2 31.2
10935 DnusA 1.9 33.0
Shown are luciferase values (x 106). MDS42 and MDS42 mutants
carrying an rrnH 16S - luc fusion were grown overnight in LB at 37C
(stationary phase), diluted 1:50, and incubated at 37C to OD600 0.20–
0.45 (log phase). Initial OD600 and viability were equivalent for the three
strains. Shown is a representative experiment; assays were performed at
least four times with equivalent results.
Table 3. NusA-DAR2 Dominant Transcription Termination
Defects at lnutRtR1
Strain nusA Plasmid b-gal units
10323 + – 176
10324 D – 343
10881 DAR2 – 902
10875 + plac-NusA 227
10876 D plac-NusA 158
10889 DAR2 plac-NusA 1114
Strains are derivatives of MDS42 and where indicated, carry a plac-
NusA+ plasmid. lacZ is expressed from the fusion lcI857 – pR – cro
(DRBS) – nutR – tR1 – cII::lacZ. Cells are assayed for b-galactosidase
activity (Miller units) after overnight growth at 42C. Strains carrying
plasmids were induced with IPTG (0.5 mM). Shown is a representative
experiment. Assayswere performed at least twice with equivalent results.
Structure
NusA:RNAP aCTD Complexsuggests that the mutation confers a gain-of-function, i.e.,
constitutive RNA binding, phenotype on NusA.
Transcription Termination Defect of nusA-DAR2
Since NusA-DAR2 is expected to bind lnut RNA constitutively,
we asked if it affected termination at ltr1, a Rho-dependent
terminator that is immediately promoter-distal to lnutR. Termina-
tionwas significantly impaired in the nusA-DAR2mutant (Table 3)
compared with wild-type or DnusA strains. The defect was not
suppressed by expression of NusA from a multicopy plasmid,
as expected if deletion of AR2 generates a gain-of-function
phenotype. In contrast to termination at ltR1, Rho-dependent
termination at ltimmwas unaffected by deletion of AR2 (Table 4).
This terminator does not lie adjacent to a nut site. We propose
that constitutive binding of NusA-DAR2 to nutR prevents access
of Rho to ltR1. Note also that the activity of the lpL promoter is
not reduced in the nusA-DAR2 strain. lpL, like the rrnH
promoters, includes an UP element (Giladi et al., 1998).
Autoinhibition of NusA Is Mediated by AR2-KH1
Interaction and Released by aCTD
AR2 blocks RNA access to the NusA-S1-KH1-KH2 (SKK)
domain (Mah et al., 2000; Nudler and Gusarov, 2003). We per-Figure 5. NusA Deletions Slow the Rate of Exit from Stationary
Phase
Strain MDS42 and its nusAmutant derivatives were grown overnight at 37C in
LB or, for plasmid-bearing strains, LB + ampicillin (50 mg/ml) and then diluted
100-fold into LB or for plasmid-bearing strains, LB + ampicillin + 0.5 mM IPTG
and grown at 37C for the times indicated. Initial OD600s and viable counts for
the 6 strains were equivalent. Strains: 10323 = wild-type (WT); 10324 = DnusA;
10881 = nusA-DAR2; 10875 = WT/ptac-NusA+; 10876 = DnusA/ptac-NusA+;
10889 = nusA-DAR2/ptac-NusA+.
Structure 19,formed NMR titration experiments with isotope-labeled NusA
SKK and AR2. The backbone resonances of NusA-SKK could
be assigned by application of multidimensional heteronuclear
transverse relaxation optimized spectroscopy (TROSY) based
triple resonance NMR. Secondary structure elements derived
from chemical shifts are consistent with known NusA structures
from other bacteria (Gopal et al., 2001;Worbs et al., 2001), allow-
ing the use of these structures as models for E. coli NusA-SKK.
HSQC NMR titration of 2H, 15N-labeled SKK with AR2 resulted in
significant chemical shift changes of resonances from the KH1
region of SKK (Figure 6A). In contrast to KH1, resonances from
the S1 and KH2 regions were not affected, suggesting that
AR2 interacts exclusively with the KH1 domain (Figures 6A, 7A,
and 7C). Addition of aCTD to the SKK:AR2 complex reversed
the chemical shift changes induced in the KH1 signals on AR2
addition (Figure 7B), confirming that aCTD promotes NusA
binding to RNA by displacing AR2 from SKK.RNA Binding of NusA-SKK
The lnutL and lnutR RNA sequences are located downstream
of the early l promotors pL and pR, respectively. The nut
sequences form stable antitermination complexes with NusA,
NusB, NusE, NusG, and lN (Nudler and Gottesman, 2002).Table 4. NusA-DAR2DoesNot Affect Termination at timm, a Rho-
Dependent Terminator Lacking a nut Site
Strain nusA Temp (C) BCM b-gal units
10900 + 32 – 51
10900 + 32 + 378
10900 + 42 – 913
10901 DAR2 32 – 31
10901 DAR2 32 + 625
10901 DAR2 42 – 430
Strains are MDS42 derivatives that carry the fusion: lpRM - lcI857 –
timm – pL – nutL – N::lacZ. At 32C, pRM is active and pL is repressed;
at 42C, pRM is repressed and pL is active. pRM transcripts terminate
at the Rho-dependent timm terminator. Cells were assayed for b-galac-
tosidase activity (Miller units) after overnight growth at 32C ± BCM
(bicyclomycin, 20 mg/ml) or at 42C. At this concentration, BCM entirely
inhibits Rho-dependent termination. Shown is a representative experi-
ment. Assays were performed at least twice with equivalent results.
945–954, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 949
Figure 6. Chemical Shift Perturbation of
NusA-SKK by AR2 and nutL RNA
(A) Chemical shift changes of NusA-SKK upon
binding to AR2 as a function of primary sequence.
(B) Chemical shift changes of NusA-SKK upon
binding to l nutL RNA as a function of primary
sequence; X = residues not assigned. Dotted line
represents the significance level of 0.04 ppm; bars
represent the three RNA binding domains.
Structure
NusA:RNAP aCTD ComplexWithin the complex, NusA binds to spacer RNA (Prasch et al.,
2009). We mapped the chemical shift perturbations of 2H, 15N-
labeled SKK by lnutL boxA-spacer-boxB RNA. Nearly all 1HN
and 15N resonances in both KH domains were affected upon
binding to lnutL RNA (Figures 6B and 7D). The most prominent
changes, however, were observed in residues Arg210 to Trp276
within the KH1 domain. The binding surface of KH1 for lnutL
boxA-spacer-boxB RNA exactly matches the binding surface
of KH1 for AR2, indicating the precision of the autoinhibitory
interaction. Our results also lend support to earlier mutational
data (Zhou et al., 2001, 2002) which showed that RNA binding
was abolished by mutating the first glycine in the conserved
GXXG motifs of KH1 (G253D) and KH2 (G319D). Both glycines
are part of the binding interface, since their resonances show
intermediate to slow exchange on the NMR time scale in the
SKK:nutL RNA complex. A third mutation, R199A, located in the
S1 domain, also abolishes nut RNA binding (Zhou et al., 2001).
Although our data show that R199 is not directly involved in bind-
ing nut RNA, it is located in the hinge connecting S1 and KH1.
The R199A mutation may impede KH1 RNA binding by changing
the relative positions of S1 and KH1. These results with E. coli
contrast studies of a complex between the M. tuberculosis
NusA and rrn boxC RNA (Beuth et al., 2005). In this complex,
rrn boxC RNA interacts predominantly with KH2.
DISCUSSION
E. coli NusA forms a complex with RNAP near the start site of
transcription. The complex is stabilized by interactions between
the NusA NTD and the b or b’ RNAP subunits, as well as by an
interaction between NusA AR2 and RNAP aCTD. Interaction
with the aCTD reverses autoinhibition by AR2 of the RNA binding
motif of NusA, allowing NusA to bind RNA.
We have solved the structure of E. coli NusA AR2 in complex
with the RNAP aCTD. In this complex, the NusA AR2 domain
interacts with the aCTD 265 determinant, which also binds UP950 Structure 19, 945–954, July 13, 2011 ª2011 Elsevier Ltd All rights reservedelements at ribosomal RNA promoters.
Indeed, NusA or isolated AR2 displaces
aCTD from UP element DNA in vitro.
Nevertheless, the rrnH operon, which
contains an UP element, was expressed
normally in strains lacking NusA or
carrying NusA with an AR2 deletion, as
monitored with an rrnH – 16S RNA – lucif-
erase fusion. As in wild-type E. coli, the
operon was highly active in log phase
cells, and downregulated in stationary
phase. We suggest that NusA does notaffect transcription initiation at rrn promoters because it enters
the transcription elongation complex after the promoters have
been cleared and sigma released, consistent with the finding
that NusA attaches to the transcription elongation complex
subsequent to Rho (Mooney et al., 2009).
Although it appears not to affect ribosomal RNA promoter
activity, NusA is known to reduce globally the rate of transcrip-
tion elongation and to stimulate termination, particularly at
intrinsic termination signals. Whether interaction between the
AR2 domain and the aCTD plays a role in these reactions is
not known.
We have further examined the phenotypes of DnusA (an inser-
tion of Cam just distal to the N-terminal domain) and nusA-DAR2
mutants. Both lag in exiting stationary phase. NusA expressed
from a plasmid suppresses the DnusA but not the nusA-DAR2
mutation. This indicates that loss of AR2 confers a dominant
gain-of-function phenotype, presumably the ability of NusA-
DAR2 to bind RNA constitutively. This phenotype suggests that
NusA N-terminal interactions are sufficient to allow NusA to
bind RNAP in the absence of AR2 interactions with aCTD,
although this has not been directly demonstrated.
We also found that termination at the Rho-dependent ltimm
terminator was unaffected by the nusA-DAR2 mutation. Unlike
ltimm, termination at ltR1, a Rho-dependent terminator that
lies just promoter-distal to lnutR, was compromised in a domi-
nant fashion by the AR2 deletion. In contrast to nusA-DAR2,
DnusA did not reduce termination at ltR1. This is most simply
explained by competition between NusA-DAR2 and Rho for
binding to the lnutR/tR1 region. We suggest that constitutive
RNA binding by the NusA-DAR2 underlies this competition.
That nusA-DAR2 has a phenotype affecting transcription elon-
gation implies that the interaction of wild-type NusA with
aCTD may be reversible during elongation, at least at the lnutR
sequence.
The structure of AR2 bound to the NusA RNA-binding motif
SKK indicates that AR2 uses the same interface to interact
Figure 7. NusA-SKK Interacts with AR2 and
nutL RNA
(A) Binding of AR2 to SKK. Chemical shift changes
of residues Arg270 and Gly249 during an NMR
titration experiment of 2H, 15N-labeled NusA-SKK
with unlabeled AR2 demonstrate binding of AR2 to
SKK.
(B) Release of autoinhibition. The direction of
titration could be reversed by adding aCTD
showing the release of NusA autoinhibition by
AR2:aCTD interaction.
(C and D) KH1 is interaction domain with AR2
and nutL RNA. Because of the 52% homology of
E. coli and Thermotoga maritima NusA-SKK
(Worbs et al., 2001), we used the crystal structure
of the latter as a template and mapped the
observed chemical shift changes onto the surface,
highlighting the binding interface of AR2 (C) and l
nutL RNA (D) (S1, light blue; KH1, gray; KH2 blue;
Residues with resonances showing chemical shift
changes of 0.04 ppm <Dd < 0.1 ppm, green; those
with Dd > 0.1 ppm, red; unassigned resonances,
yellow). Bottom: structure of nutL RNA as used in
the titration experiment.
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NusA:RNAP aCTD Complexwith the aCTD and with KH1, indicating that AR2 binding to
aCTD completely precludes binding to the KH1 motif. Interest-
ingly, the interactions between AR2 and the RNA-binding motif
are exclusively with KH1. This suggests that KH1 is the dominant
RNA-binding motif, consistent with analysis of NusA point
mutant proteins, although the S1 motif is also thought to partic-
ipate in RNA binding (Zhou et al., 2002).Structure 19, 945–954, July 13, 2011It will be interesting to determine the
mechanistic defects of the nusA point
mutations, nusA1 and nusA100, which
block l N and/or HK022 Nun function
and which lie in the S1 motif.
EXPERIMENTAL PROCEDURES
Protein Preparation
E. coli AR1 (residues 339–426) and AR2 (residues
424–495) were expressed as a deca-histidine-
tagged protein in BL21(DE3) from pET-19b
(Novagen) and purified as described previously
(Eisenmann et al., 2005; Prasch et al., 2006).
E. coli aCTD (residues 233–329) was expressed
as a deca-histidine-tagged protein in BL21(DE3)
from pET-19b (Novagen) and purified as de-
scribed previously (Eisenmann et al., 2005).
E. coli NusA-SKK (residues 132–348) was ex-
pressed as a penta-histidine-tagged protein in
BL21(DE3) from pET-11a (Novagen) as described
previously (Mah et al., 1999).
In brief, strains carrying these constructs were
grown in M9 minimal medium supplemented with
15NH4Cl and 0.2%
13C D-glucose as the sole
nitrogen and carbon sources, respectively (Marley
et al., 2001). To improve the resolution and sensi-
tivity of the NMR spectra, deuterated M9 minimal
medium supplemented with 15NH4Cl and 0.2%
13C D-glucose has been used for NusA-SKK.
In the case of AR1, AR2, and aCTD, the re-
combinant proteins were purified under nativeconditions by nickel-affinity chromatography (5 ml His-trap chelating column,
GE Health Care) and eluted by applying an imidazole step gradient. Peak frac-
tions containing the constructs were dialyzed against 50mM Tris/HCl (pH 8.0),
150 mM NaCl, and 1 mM DTT. After dialysis, the N-terminal deca-His tag was
cleaved off using PreScission protease. The cleaved proteins were dialyzed
against 50 mM Tris/HCl (pH 7.4) and 1 mM DTT and further purified via a
QXL column (GE Health Care) by a NaCl step gradient in the same buffer
with up to 1 M NaCl. The eluted fractions containing the proteins wereª2011 Elsevier Ltd All rights reserved 951
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NusA:RNAP aCTD Complexconcentrated with Vivaspin concentrators (Vivascience, MWCO 5000 Da) and
dialyzed against NMR buffer. NMR samples contained 0.5–1.5 mM AR1, AR2,
or aCTD in 10mM potassium phosphate (pH 6.8), 50 mMNaCl, 0.02% sodium
azide, and 10%D2O. For the complex sample we used a stoichiometric ratio of
AR2:aCTD of 1:3, or vice versa.
In the case of NusA-SKK, the recombinant protein was purified under native
conditions by nickel-affinity chromatography (5 ml His-trap chelating column,
GE Health Care) and eluted by applying an imidazole step gradient. Peak
fractions containing the constructs were dialyzed against 50 mM sodium
phosphate buffer (pH 7.6), 100 mM NaCl, 10 mM b-mercaptoethanol,
0.5 mM EDTA, and 1% glycerol (v/v) and concentrated with Vivaspin concen-
trators (Vivascience, MWCO 10,000 Da).
NMR Spectroscopy
All NMR spectra were recorded at 298 K on Bruker Avance 700 MHz and
Avance 800 MHz spectrometers with cryogenically cooled triple-resonance
probes equipped with pulsed field-gradient capabilities.
For resonance assignment of NusA-AR2 and aCTD in their complex stan-
dard double and triple resonance through-bond experiments were recorded
(Sattler et al., 1999) using differential isotopically labeled samples (uniformly
13C,15N-labeled AR2 and unlabeled aCTD and vice versa). For NusA-SKK,
assignment was done using TROSY-type NMR experiments (Pervushin
et al., 1997; Salzmann et al., 1998) and 15N-edited NOESY spectra. For obtain-
ing distance restraints 15N-separated and 13C-separated nuclear Overhauser
enhancement (NOE) experiments were recorded (Ikura et al., 1991; Talluri
and Wagner, 1996). Intermolecular NOEs were recorded with one partner
15N/13C-labeled and the other unlabeled in D2O using three-dimensional
13C-separated/12C-filtered NOE experiments (Zwahlen et al., 1997). NMR
data were processed using in-house routines and visualized with NMRView
(Johnson, 2004). Dissociations constants were determined from chemical shift
changes of residues showing fast exchange behavior during a titration
experiment using a two-state model.
Structure Determination
Distance restraints for structure calculation were derived from 15N-NOESY-
HSQC and 13C-NOESY-HSQC spectra with mixing times of 100–120 ms.
NOESY cross peaks were classified according to their relative intensities and
converted to distance restraints with upper limits of 3.0 A˚ (strong), 4.0 A˚
(medium), 5.0 A˚ (weak), and6.0 A˚ (veryweak). Forambiguousdistance restraints
the r-6 summationover all assignedpossibilitiesdefined theupperdistance limit.
Hydrogen bonds were included for backbone amide protons in regular
secondary structure if the amide proton did not show a water exchange cross
peak in the 15N-edited NOESY spectrum or showing slow exchange in H/D
exchange experiments . The structure calculations were performed with the
program XPLOR-NIH 1.2.1(Schwieters et al., 2003) using a three-step simu-
lated annealing protocol with floating assignment of prochiral groups including
a conformational database potential. The structures were analyzed with the
programs XPLOR-NIH 1.2.1 and PROCHECK (Laskowski et al., 1996).
Competition gel Retardation Assay
Synthetic oligonucleotides were purchased from biomers.net (Ulm, Germany).
Annealing was promoted by incubation of the appropriate oligonucleotides
at 95C for 5 min, with cooling down at room temperature in NMR buffer
(10 mM potassium phosphate [pH 6.8], 50 mM NaCl). The oligonucleotides
were 50-end labeled with [32P] ATP using T4 polynucleotide kinase (NEB). Unin-
corporated label was removed using a 1 ml G25 spin column (GE Healthcare).
Competition gel retardation assays (10 ml) were performed in NMR buffer
(10 mM potassium phosphate [pH 6.8], 50 mM NaCl). Binding reactions typi-
cally contained 100 mM unlabelled DNA with 0.16 mM [32P]-labeled DNA,
with increasing concentrations of binding protein or competitor protein in a final
reaction volume of 10 ml. The reactions were analyzed in 6% nondenaturing
polyacrylamide gels (Novex Pre-Cast DNA Retardation Gels, Invitrogen) in
1/23 TBE buffer, and electrophoresed at 80 V for 90 min at 4C and visual-
ized with a phosphoimager.
Construction of 16S rRNA-luc and aspU-luc Gene Fusions
The 16S rRNA-luc gene fusion was constructed in the rrnH rRNA gene operon
of the E. coli chromosome to assay the transcription activity within rRNA gene952 Structure 19, 945–954, July 13, 2011 ª2011 Elsevier Ltd All rightoperons in vivo. The construction of the fusion was done in two steps using re-
combineering (Thomason et al., 2007). First, the luc/amp gene cassette was
assembled in the chromosome of JS470 so that the luc gene could be trans-
ferred between various genetic backgrounds using amp as a genetic marker.
Then, the luc/amp cassette was used to make the rrnH-luc fusion in NB363
replacing the rrsH-aspU region, rrsH-aspU < > luc/amp.
The luc/amp gene cassette was assembled by placing the ampicillin resis-
tance amp gene just downstream to the firefly luciferase luc gene in the
galK < > luc chromosomal locus of JS470 (kindly provided by Dr. J. Sawitzke),
a derivative of the recombinogenic DY330 strain containing a defective l
prophage expressing the red recombination genes. The amp gene with its
own promoter was amplified by PCR (Platinum Taq DNA Polymerase High
Fidelity, Invitrogen, CA) from pBR322 using the forward primer CGGAAAG
ATCGCCGTGTAAACGAAACTCCCGCACTGGCACCCGATCATTCAAATATG
TATCCGCTC and the reverse primer CATCCCTGCGTTGTTACGCAAAGT
TAACAGTCGGTACGGCTGACCTTACCAATGCTTAATCAGTGAGGC. These
bipartite primers were designed so that the last 23 bases at the 30 end of the
primers (shown in bold) provided sequences for amplification of the amp
gene, whereas the first 45 bases provided sequences homologous to the
galK < > luc downstream target region which are required for recombination
of the PCR-amplified amp gene into that region of the E. coli chromosome.
The resulting amp gene PCR product was purified by the PCR Purification
Kit (QIAGEN) and 100 ng of the product was used to transform JS470 heat-
induced for recombineering at A600 0.4 for 15 min. as previously described
in detail for DY330 (Bubunenko et al., 2007). The transformed cells were grown
for 3 hr at 32C and plated on L plates containing 30 mg/ml Amp (Ap30). The
plates were incubated for 2 days at 32C and the recombinants analyzed by
PCR for amp using a pair of checking primers flanking the chromosomal
amp insertion: AACTCGACGCAAGAAAAATCAGAG and GTCGCACCCCAG
TCCATCAGCGTG. The resulting NB371 cells were used as a source of the
luc/amp cassette.
To make the 16S rRNA-luc fusion, the luc/amp cassette was amplified by
PCR using the forward primer AATTCATTACAAAGTTTAATTCTTTGAGCATC
AAACTTTTGAAGGAGATATTCATATGGAAGACGCCAAAAACATAAAG and
the reverse primer CTTATTAAGAAGCCTCGAGTTAACGCTCGAGGTTTTTTTT
CGTCTTTACCAATGCTTAATCAGTGAGGC. In these bipartite primers, the
last 24 bases (shown in boldface) provided the regions for amplification of
luc/amp. The first 55 bases of the forward primers and 45 bases of the reverse
primer provided the regions of homology to the respective target regions of the
chromosomal rrnH rRNA gene operon. The PCR-amplified fragments were
purified and used to transform NB363, a W3110 derivative containing a
minil-tet expressing the red recombination genes (Court et al., 2003). Recom-
bineering was done as described above for JS470. The cells were plated on
Ap30 plates and the recombinants screened for the luc-amp insertions by
PCR using a pair of checking primers flanking the rrsH-aspU region, TACCA
AGTCTCAAGAGTGAACACG and GCAGGGATAGCCATAATATGCCTC or
the aspU gene, CGCCGAAGCTGTTTTGGCGGATTG and GCAGGGATAGCC
ATAATATGCCTC respectively. The minil-tet was removed from the final
NB375 (W3110 rrsH-aspU < > luc/amp) strain by growing cells at 37C and
selecting for TcS colonies.
Strains and Enzyme Assays
Strains were derivatives of MDS42, which lacks prophages an2d insertion
elements (Posfai et al., 2006). A pBR322-based plasmid (pRW1; Watnick,
and Gottesman, 1998) that expressed LacZ under ptaq control was used for
complementation studies. Standard b-galactosidase and luciferase assays
were used. Details are described in the Table legends.
ACCESSION NUMBERS
NMR resonance assignments were deposited in the BMRB under the acces-
sion codes 15614. Coordinates and restraints for structure calculation were
deposited in the PDB under accession code 2JZB.
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